Arctic Cat v. Bombardier (S.D. Fla., Fed. Cir., S. Ct.): Successfully represented patent owner and plaintiff Arctic Cat in opposing Bombardier’s petition for a writ of certiorari, confirming the judgment of willful patent infringement and award of treble damages. Representing Arctic Cat in ongoing district court and appellate proceedings involving Arctic Cat’s patented personal watercraft technology.
Eli Lilly v. Dr. Reddy’s (Fed. Cir.): Representing Dr. Reddy’s as defendant in an appeal from a Hatch-Waxman patent-infringement trial involving chemotherapy compositions.
Arkema v. Honeywell (P.T.A.B., Fed. Cir.): Representing Honeywell as patent owner in a PTO post-grant review proceeding and a Federal Circuit appeal involving automobile refrigerant compositions.
Allergan v. Sandoz (D.N.J., Fed. Cir.): Representing Sandoz as defendant in a three-patent Hatch-Waxman suit involving eye drops for treating ocular hypertension.
Endo v. Teva (Fed. Cir.): Representing Teva as defendant in several appeals from Hatch-Waxman patent-infringement trials involving an opioid analgesic.
UCB v. Actavis (Fed. Cir.): Representing Actavis as defendant in an appeal from a Hatch-Waxman patent-infringement trial involving transdermal patches for treating Parkinson’s disease.
Cisco v. Arista (Fed. Cir.): Representing Cisco as patent owner in several appeals from inter partes review proceedings in the PTO involving networking technologies.
Janssen Biotech v. Celltrion Healthcare (Fed. Cir.): Successfully represented Celltrion as defendant in a BPCIA patent-infringement appeal. The Federal Circuit dismissed Janssen’s district court appeal as moot after affirming the invalidity of all asserted claims in a companion appeal from the PTO.
Allergan v. Sandoz, 717 F. App’x 991 (Fed. Cir. 2017), cert. denied -- S.Ct. -- (2018): Successfully represented Sandoz as defendant in an appeal from a three-patent Hatch-Waxman suit. The Federal Circuit affirmed Sandoz’s non-infringement of two patents and reversed the district court’s infringement judgment as to the third. Successfully opposed Allergan’s petition for rehearing.
